A detailed history of Deep Track Capital, LP transactions in Geron Corp stock. As of the latest transaction made, Deep Track Capital, LP holds 7,575,049 shares of GERN stock, worth $26.4 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
7,575,049
Previous 13,000,000 41.73%
Holding current value
$26.4 Million
Previous $55.1 Million 37.61%
% of portfolio
1.27%
Previous 1.81%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $22.6 Million - $27.1 Million
-5,424,951 Reduced 41.73%
7,575,049 $34.4 Million
Q2 2024

Aug 14, 2024

SELL
$3.1 - $5.09 $54.3 Million - $89.1 Million
-17,505,929 Reduced 57.39%
13,000,000 $55.1 Million
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $1.61 Million - $3.17 Million
922,480 Added 3.12%
30,505,929 $101 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $6.76 Million - $8.97 Million
3,883,449 Added 15.11%
29,583,449 $62.4 Million
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $3.23 Million - $5.02 Million
1,529,034 Added 6.33%
25,700,000 $54.5 Million
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $5.31 Million - $9.95 Million
-2,696,513 Reduced 10.04%
24,170,966 $77.6 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $41.6 Million - $66.1 Million
19,452,786 Added 262.35%
26,867,479 $58.3 Million
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $15.1 Million - $17.9 Million
7,414,693 New
7,414,693 $17.9 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.